Cardinal Health, Inc. $CAH Shares Acquired by Personal CFO Solutions LLC

Personal CFO Solutions LLC boosted its holdings in Cardinal Health, Inc. (NYSE:CAH) by 176.1% in the 1st quarter, Holdings Channel reports. The firm owned 5,615 shares of the company’s stock after purchasing an additional 3,581 shares during the period. Personal CFO Solutions LLC’s holdings in Cardinal Health were worth $1,186,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Aventura Private Wealth LLC purchased a new stake in shares of Cardinal Health in the fourth quarter valued at about $25,000. University of Texas Texas AM Investment Management Co. purchased a new position in shares of Cardinal Health during the fourth quarter worth about $26,000. Bank of Jackson Hole Trust purchased a new position in shares of Cardinal Health during the fourth quarter worth about $27,000. Jones Financial Companies Lllp increased its position in Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after acquiring an additional 14,034 shares during the period. Finally, Palladiem LLC purchased a new stake in Cardinal Health during the 4th quarter valued at approximately $28,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Trading Down 1.0%

Shares of CAH opened at $237.41 on Thursday. The stock’s 50 day moving average is $211.13 and its two-hundred day moving average is $212.62. Cardinal Health, Inc. has a twelve month low of $137.75 and a twelve month high of $243.21. The firm has a market capitalization of $55.60 billion, a PE ratio of 36.30, a P/E/G ratio of 1.18 and a beta of 0.49.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. The business had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The company’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same period in the prior year, the business posted $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, sell-side analysts predict that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be given a $0.5158 dividend. The ex-dividend date is Wednesday, July 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is currently 31.50%.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the company. TD Cowen increased their price objective on Cardinal Health from $251.00 to $255.00 and gave the stock a “buy” rating in a research report on Friday, May 1st. Morgan Stanley upped their price target on Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 28th. JPMorgan Chase & Co. decreased their price target on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a report on Monday, May 4th. Evercore lowered their price objective on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 8th. Finally, William Blair began coverage on shares of Cardinal Health in a research note on Tuesday, April 28th. They issued an “outperform” rating on the stock. Fifteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $247.80.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.